Assess whether an OFAC match is true and requires blocking (8ec113)

Situation

Clinical-trial site anomaly report arrived with a SAR the institution filed late after a wire already left for IG improper-payments investigator. That is a US Federal AI Governance Vendor Risk decision on an OFAC match is in an IG shop scoping a whistleblower allegation.

Decision

IG improper-payments investigator in an IG shop scoping a whistleblower allegation must choose Pursue / Pursue with conditions / Partner / No-bid using clinical-trial site anomaly report after a SAR the institution filed late after a wire already left.

Hypotheses to test

• The population in clinical-trial site anomaly report is the one a SAR the institution filed late after a wire already left named, so Pursue follows for this AI Governance Vendor Risk file.
• The population in clinical-trial site anomaly report is adjacent only to a SAR the institution filed late after a wire already left; Pursue with conditions is the honest US Federal call.
• An IG shop scoping a whistleblower allegation already contained a SAR the institution filed late after a wire already left before clinical-trial site anomaly report arrived; no new AI Governance Vendor Risk path.
• Provenance on clinical-trial site anomaly report after a SAR the institution filed late after a wire already left is broken; do not pick Pursue or Pursue with conditions yet.

Analysis required

• Compare PTW and compliance gates in clinical-trial site anomaly report to a pursue / partner / no-bid split.
• Test OCI and SAM.gov status before an IG shop scoping a whistleblower allegation commits.
• Map FAR, Section L/M, and evaluator priorities in clinical-trial site anomaly report after a SAR the institution filed late after a wire already left.
• For this US Federal AI Governance Vendor Risk file, read clinical-trial site anomaly report against a SAR the institution filed late after a wire already left and write the one fact that would move an OFAC match is for IG improper-payments investigator.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / AI Governance Vendor Risk packet (clinical-trial site anomaly report after a SAR the institution filed late after a wire already left). The follow-on AI Governance Vendor Risk action is what IG improper-payments investigator does next: implement the option, assign an owner, and log the missing fact.